| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-14 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.46 | 5e-13 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-12 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-11 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.35 | 9e-07 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.35 | 9e-07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.18 | 9e-07 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |